Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Are rapid weight loss drugs hiding the real obesity problem?

Martha Rosenberg
Meds
August 10, 2024
Share
Tweet
Share

According to some academics, in 2019, a ban on junk food advertising across London’s entire public transport network—foods and drinks high in fat and salt and ads for foods–resulted in the prevention of 100,000 obesity cases. Yet the U.S. love affair with the new semaglutide-based weight loss drugs like Ozempic gives junk food advertising and availability a huge pass.

Drug makers and Wall Street are pleased that instead of changing their eating habits, fat people are rushing toward drugs that can be listed at $935.77 per single dose (compute that annually!), raising everyone’s health care costs and taxes from entitlement programs like Medicare. People who don’t overeat are carrying the cost weight, pun intended, along with fat people.

Like Vioxx, reported to have caused between 88,000 and 140,000 cases of serious heart disease and statins linked to diabetes mellitus, liver damage, and cognitive decline, drug makers clearly think they now have a new blockbuster on their hands with the rapid weight loss drugs. In fact, in its day, the medical establishment and public were so enthralled with statins like Lipitor that it was proposed the drug should be put in the drinking water! You can have your bacon cheeseburger with an egg on top and still avoid heart disease, emoted fans. Then the long-term side effects emerged.

But despite efforts from drug makers, the medical establishment, and news outlets with lucrative drug ads to float the new rapid weight loss as dietary saviors addressing a host of problems — they diminish heart risks and addiction, their cheerleaders breathlessly chant––there are serious concerns which will no doubt surface when the blockbuster goes off patent. Surgeons I have interviewed cite life-threatening risks on the operating table from the drugs due to the delayed food digestion they cause. And the drugs are linked to eye risks, negative mental effects, thyroid tumors, pancreatitis, hypoglycemia, gallbladder issues, kidney failure, cancer, and gallbladder conditions requiring hospitalization. Such a deal.

While the drugs’ popularity is driven by vanity among those who overeat and are fat — making it especially popular in Hollywood — it also can cause an ugly, sagging, and old-looking face from the rapid weight loss. (Years ago, supermodels used to say that after a certain age, women had to “choose between their butt and their face” when it came to their appearance.)

As the undesirable side effects emerge as people take the drugs over time––including a rapid gain of weight when the drug is stopped, leading to a de facto “addiction”––will the drugs be so popular in a year or two? Signs suggest no.

Americans have become huge.

The average American man weighs 194 pounds today, and the average woman weighs 165 pounds. Everything from airline seats to coffins to hospital operating tables to amusement park seats has been redesigned to accommodate this gross national product, and its cause is clearly evident.

Look at photos of Americans 20 or 30 years ago, and they have cheekbones, waistlines, and clothes that do not hide their obesity. It’s the food. In addition to ads for fattening, cholesterol- and high fructose-syrup-laden food everywhere, from the TV to commuter train stations, junk food is ubiquitous. It is found in banks, hardware stores, car washes, and even hospitals.

Not only do people wolf down junk food as ads tell them to do, but an insidious movement tells doctors if they mention fat people’s fat, they are “fat shaming.” But obesity causes heart disease, stroke, Type 2 diabetes, fatty liver disease and increases COVID-19 seriousness and is linked to cancers of the uterus, cervix, endometrium, ovary, breast, colon, rectum, esophagus, liver, gallbladder, pancreas, kidney and prostate. There is no such thing as “fit but fat.” If doctors mention a patient’s smoking are they “nicotine shaming”?

The fat acceptance and anti-sizeism movement want the medical profession to enable junk food-related obesity which is especially prevalent in marginalized communities. The move is driven by the politically correct, powerful “woke” movement that says you are not over-eating and fat; you’re a large and big-boned person who is (somehow) born that way. It is not a harmless movement, and doctors should not be silenced. People who do not overeat and are normal-sized pay for the mortality and morbidity of fat people who are told their obesity is not their fault.

While the public, drug makers, the medical establishment, and Wall Street may be enamored with the new rapid weight loss drugs, it is time public health officials address the junk food, junk food advertising, and junk food ubiquity that are behind obesity in the U.S. and elsewhere. It may be making a killing in profits but it is killing its victims.

Martha Rosenberg is a health reporter and the author of Big Food, Big Pharma, Big Lies and Born With a Junk Food Deficiency.  

Prev

A journey of self-worth and healing [PODCAST]

August 9, 2024 Kevin 0
…
Next

Why speaking up in medical school could save lives

August 10, 2024 Kevin 0
…

ADVERTISEMENT

Tagged as: Obesity

Post navigation

< Previous Post
A journey of self-worth and healing [PODCAST]
Next Post >
Why speaking up in medical school could save lives

ADVERTISEMENT

More by Martha Rosenberg

  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg

Related Posts

  • Unveiling the game-changing diabetic drugs: Revolutionizing weight loss and diabetes management

    Dinesh Arab, MD
  • AI’s role in streamlining colorectal cancer screening [PODCAST]

    The Podcast by KevinMD
  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • Pandemic aftermath: Navigating a new normal in health, education, and social dynamics

    Susan Levenstein, MD
  • Medicare’s 14-day rule is hurting cancer patients

    Sean Jordan, MD
  • How weight loss drugs are creating a medical dilemma

    Yasmine Kamgarhaghighi

More in Meds

  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Why billionaires dress like college students

      Osmund Agbo, MD | Physician
    • The therapy memory recall crisis

      Ronke Lawal | Conditions
    • A urologist explains premature ejaculation

      Martina Ambardjieva, MD, PhD | Conditions
    • Why medical organizations must end their silence

      Marilyn Uzdavines, JD & Vijay Rajput, MD | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reclaiming physician agency in a broken system

      Christie Mulholland, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Why billionaires dress like college students

      Osmund Agbo, MD | Physician
    • The therapy memory recall crisis

      Ronke Lawal | Conditions
    • A urologist explains premature ejaculation

      Martina Ambardjieva, MD, PhD | Conditions
    • Why medical organizations must end their silence

      Marilyn Uzdavines, JD & Vijay Rajput, MD | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reclaiming physician agency in a broken system

      Christie Mulholland, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...